JAVID MOSLEHI

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease SAN FRANCISCO, CA NPI 1538123716

General Payments — all program years on this page

$381,220.93

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 146
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $31,247.13 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $31,129.509
Food and Beverage $117.631

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $105,531.1113
2019 $33,394.2146
2020 $95,817.9817
2021 $33,405.5016
2022 $29,248.2516
2023 $52,576.7528
2024 $31,247.1310

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086192346 Bayer Healthcare Pharmaceuticals Inc. $7,700.00 12/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087124946 Novartis Pharmaceuticals Corporation $2,400.00 01/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089459886 Daiichi Sankyo Inc. $2,700.00 05/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089459888 Daiichi Sankyo Inc. $675.00 07/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1103098271 Immunocore Limited $2,888.00 06/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104568142 AstraZeneca Pharmaceuticals LP $7,786.50 04/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105429666 AstraZeneca Pharmaceuticals LP $2,397.50 10/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105463619 AstraZeneca Pharmaceuticals LP $1,712.50 06/21/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141423633 SOBI, INC $2,870.00 12/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1154870546 Kiniksa Pharmaceuticals International, plc $117.63 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.